Review
Open access
Oct 2026
SGLT-2 inhibitor add-on to DPP-4 inhibitor therapy significantly reduces HbA1c and body weight without increasing hypoglycaemia risk in type 2 diabetes inadequately controlled on metformin: a systematic review and meta-analysis
Arif Saleem, Haris Shinwari, Muhammad Usman et al.
· Diabetology International · 0 citations